Atlas Molecular Pharma
Derio
About Atlas Molecular Pharma
Atlas Molecular Pharma is focused on the discovery of first-in-class, innovative therapeutics for the treatment of patients suffering from Rare and Ultra-Rare Diseases. Its line of work focuses on the development of a proprietary technology that enables the identification of molecules / drugs that provide stability to certain proteins whose dysfunction is responsible for the development of a large part of these rare diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $3.4M
- Last round: Series Unknown (Feb 2022)
- Website: atlasmolecularpharma.com
- Phone: +34 944061300
Industries & Categories
Biotechnology, Life Science, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/atlas-molecular-pharma-99304 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.